Clinical Trial

Hugo™ Robotic-Assisted Surgery (RAS) System in Gynecological Subjects (Embrace Gynecology)

Study acronym: Embrace Gyn
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this research is to evaluate the safety and performance of the investigational Medtronic Hugo™ Robotic Assisted Surgery (RAS) system when used during hysterectomy procedures, including patients being treated for cancer.
Protocol Amendment History 1 change
critical Trial status changed: Recruiting → Active, Not Recruiting 2026-06-03
Trial Details
NCT Number NCT07120945
Lead Sponsor Medtronic - MITG
Conditions Uterine Fibroids (UF), Menstrual Disorders, Adenomyosis of Uterus, Endometriosis, Uterine Prolapse, Precancerous/Nonmalignant Condition, Cervical Cancer, Endometrial Cancer +1 more
Enrollment 70 participants
Start Date 2025-08-28
Primary Completion 2026-02-25 (estimated)
Study Completion 2031-05 (estimated)
Updated on ClinicalTrials.gov 2026-06-02